Nebraska Cancer Action Center

Share

Action Center

The right treatment at the right time: Support LB 253

Biomarker testing looks at an individual patient’s cells (often from a biopsy or blood test) to identify mutations or other markers that help doctors determine which treatment will be most effective. 

Latest Updates

May 13, 2025
Nebraska

OMAHA, Neb. – This week, the American Cancer Society Cancer Action Network (ACS CAN) is staging a digital takeover nationwide, including here in Nebraska, calling on Congress to protect Medicaid. The House of Representatives Energy and Commerce Committee will be voting this week on proposed cuts to Medicaid and ACS

January 29, 2025
Nebraska

This letter originally ran in the Lincoln Journal Star . Biomarker testing opens the door to precision medicine, which can increase survivorship and quality of life for cancer patients. Precision medicine is revolutionizing cancer care, and people need access to it. As a volunteer with the American Cancer Society

January 8, 2025
Nebraska

LINCOLN, Neb . – Statement from Megan Word, American Cancer Society Cancer Action Network (ACS CAN) Nebraska government relations director: “As lawmakers dive into the 2025 legislative session, ACS CAN urges lawmakers to prioritize passing legislation to ease the burden of cancer on Nebraskans. “ACS CAN calls on the legislature

August 8, 2024
Nebraska

Action Needed to Reduce the Burden of Cancer on Nebraskans  

State Contacts

Holly Kaffenberger
Nebraska Grassroots Manager
Megan Word
Nebraska Government Relations Director
Michael DuPré
Associate Director, Regional Media Advocacy

Share Your Story

Do you have a personal story about how cancer has impacted you or someone you love? Real stories are how ACS CAN ensures that no one becomes a statistic.